Agape ATP (ATPC) Competitors $2.33 +0.03 (+1.30%) As of 03:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ATPC vs. CELC, INNV, EHAB, LFMD, SBC, PSNL, VMD, DCGO, TOI, and AIRSShould you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Celcuity (CELC), InnovAge (INNV), Enhabit (EHAB), LifeMD (LFMD), SBC Medical Group (SBC), Personalis (PSNL), Viemed Healthcare (VMD), DocGo (DCGO), Oncology Institute (TOI), and AirSculpt Technologies (AIRS). These companies are all part of the "healthcare" industry. Agape ATP vs. Celcuity InnovAge Enhabit LifeMD SBC Medical Group Personalis Viemed Healthcare DocGo Oncology Institute AirSculpt Technologies Agape ATP (NASDAQ:ATPC) and Celcuity (NASDAQ:CELC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Do analysts rate ATPC or CELC? Celcuity has a consensus price target of $30.17, indicating a potential upside of 175.82%. Given Celcuity's stronger consensus rating and higher possible upside, analysts plainly believe Celcuity is more favorable than Agape ATP.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Which has more volatility and risk, ATPC or CELC? Agape ATP has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Does the media favor ATPC or CELC? In the previous week, Agape ATP and Agape ATP both had 6 articles in the media. Celcuity's average media sentiment score of 1.36 beat Agape ATP's score of 0.55 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ATPC or CELC more profitable? Celcuity has a net margin of 0.00% compared to Agape ATP's net margin of -194.09%. Celcuity's return on equity of -62.66% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Agape ATP-194.09% -74.71% -56.08% Celcuity N/A -62.66%-39.78% Do institutionals and insiders believe in ATPC or CELC? 0.0% of Agape ATP shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 9.7% of Agape ATP shares are held by company insiders. Comparatively, 15.8% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community prefer ATPC or CELC? Celcuity received 341 more outperform votes than Agape ATP when rated by MarketBeat users. CompanyUnderperformOutperformAgape ATPN/AN/ACelcuityOutperform Votes34167.79% Underperform Votes16232.21% Which has higher valuation and earnings, ATPC or CELC? Agape ATP has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgape ATP$1.32M88.08-$2.10M-$0.73-3.19CelcuityN/AN/A-$63.78M-$2.81-3.89 SummaryCelcuity beats Agape ATP on 12 of the 16 factors compared between the two stocks. Get Agape ATP News Delivered to You Automatically Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATPC vs. The Competition Export to ExcelMetricAgape ATPHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$116.51M$839.95M$5.50B$7.98BDividend YieldN/A2.55%5.11%4.23%P/E Ratio-3.1953.4722.6318.59Price / Sales88.087.99398.09103.52Price / CashN/A26.1438.1834.62Price / Book2.043.996.724.27Net Income-$2.10M-$5.50M$3.22B$248.18M7 Day Performance4.95%-2.65%1.58%1.47%1 Month Performance83.46%4.48%4.09%3.96%1 Year Performance-61.10%16.84%16.05%5.57% Agape ATP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATPCAgape ATP0.3163 of 5 stars$2.33+1.3%N/A-53.6%$116.51M$1.32M-3.1940CELCCelcuity2.6311 of 5 stars$11.22+1.2%$30.17+168.9%-29.4%$424.55MN/A-4.3040Short Interest ↓Analyst RevisionPositive NewsINNVInnovAge1.3907 of 5 stars$3.05flat$5.00+63.9%-11.8%$412.49M$806.61M-16.052,000Upcoming EarningsNews CoverageGap DownEHABEnhabit1.5633 of 5 stars$7.95+0.2%$8.50+7.0%-21.1%$401.06M$1.03B-3.4210,900Upcoming EarningsNews CoveragePositive NewsLFMDLifeMD2.4302 of 5 stars$8.62+41.3%$11.00+27.6%-38.3%$384.31M$212.45M-13.47230Upcoming EarningsAnalyst ForecastOptions VolumeNews CoverageHigh Trading VolumeSBCSBC Medical GroupN/A$3.35-6.4%N/AN/A$347.10M$205.42M0.00N/AGap UpPSNLPersonalis3.6329 of 5 stars$3.80+1.3%$7.80+105.3%+157.1%$335.57M$84.61M-2.26400Upcoming EarningsVMDViemed Healthcare1.7484 of 5 stars$6.95-1.7%N/A-13.7%$274.68M$224.26M25.74630Upcoming EarningsShort Interest ↓News CoveragePositive NewsDCGODocGo2.5776 of 5 stars$2.28+1.8%$4.89+114.5%-34.0%$232.52M$616.56M8.142,920Upcoming EarningsPositive NewsTOIOncology Institute0.7202 of 5 stars$2.50-14.1%N/A+134.0%$188.90M$393.41M-3.21660Positive NewsHigh Trading VolumeAIRSAirSculpt Technologies1.5753 of 5 stars$2.24+6.2%$3.75+67.4%-60.6%$131.21M$180.35M-16.00240Negative NewsGap Down Related Companies and Tools Related Companies CELC Competitors INNV Competitors EHAB Competitors LFMD Competitors SBC Competitors PSNL Competitors VMD Competitors DCGO Competitors TOI Competitors AIRS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATPC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agape ATP Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agape ATP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATPC Stock Free ATPC Stock Alerts